Uniplan Investment Counsel’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FAM
Uniplan Investment Counsel's NEO Position: Q2 2021 in Review
Uniplan Investment Counsel sold out of NeoGenomics (NEO) in Q2 2021, closing a stake of 60,049 shares — an estimated $2.9M sold.
Uniplan Investment Counsel first reported a position in NEO in Q2 2015 and held it in 24 quarters. The position peaked at $11.2M in Q4 2020. 311 funds tracked by Wall St. Rank hold NEO as of Q2 2021.
- Uniplan Investment Counsel reported no remaining NeoGenomics position as of Q2 2021 after selling out during the quarter.
- Uniplan Investment Counsel sold 60,049 NeoGenomics shares in Q2 2021, an estimated $2.9M.
- Uniplan Investment Counsel first reported a position in NeoGenomics in Q2 2015 and held it in 24 quarters.
- Uniplan Investment Counsel's NeoGenomics position peaked at $11.2M in Q4 2020.
- 311 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2021.
Based on Uniplan Investment Counsel's 13F filing for Q2 2021, filed 13 Aug 2021.